An all-encompassing term to describe protein complexity

Neil Kelleher and Lloyd Smith propose that the scientific community adopt the term ‘proteoform’ to refer to all the different forms that a protein can take. Will the community adopt it?

The field of top-down proteomics, in which intact proteins are analyzed by a mass spectrometer, provides rich information about the genetic variations, alternative splicing and post-translational modifications that can be lost in a bottom-up proteomics approach (where proteins are digested into peptides prior to analysis). An unsolved problem in the top-down field, however, has been what exactly to call these various protein forms. Besides ‘protein forms’, a handful of other terms have been batted around in the literature, including ‘protein variants’, ‘protein isoforms’ and ‘protein species.’

In a Correspondence in the March issue of Nature Methods, Neil Kelleher and Lloyd Smith lay out the reasons why none of these terms are satisfactory. What is needed, they argue, is a novel, unique, intuitive, single-word term with a precise definition that is all-encompassing in describing protein complexity, and is also compatible with a gene-centric approach to protein naming. They believe that they have the perfect term: proteoform.

“It’s not just a term, it’s a movement,” says Kelleher. Kelleher has been one of the key drivers of top down methodology development, and argues that using a controlled vocabulary to describe proteins will serve a catalytic role in moving the field forward. “The implicit thing about this term is that it puts a focal point on the fact that [the proteoforms] are the functional players, insofar as protein primary structure is concerned,” he says. Especially in clinical research, he notes, different proteoforms are tied strongly to function and phenotype.

Kelleher and Smith have been gathering support for their term over the last several months by introducing it at conferences and inviting researchers to comment on a LinkedIn forum. The term also has the full support of the Consortium for Top Down Proteomics. At their latest conference in Florida, about a month ago, Kelleher says that “everyone” was using “proteoform” in their talks. “It just catches on…it fills a void the rolls right off the tongue at conferences and sits well in the gut while digesting text,” he says. The consortium website maintains a repository of proteoforms, which they hope will grow. Kelleher also notes that the term is being embraced by key protein informatics players at UniProt and the Protein Information Resource, both of which have adopted a gene-centric approach to protein naming.

What do you think about the term “proteoform”? Will you adopt it? We’d love to hear from you!

Return of the Points of View column

Our popular “Points of View” column returns this month after a brief hiatus. Here is a bit of history of the column and an introduction to its new author.

On this day four years ago Sean O’Donoghue contacted Nature Methods about a workshop he was organizing on visualizing biological data. This culminated in a Nature Methods Supplement on Visualizing Biological Data published one year later that coincided with the first VizBi meeting in Heidelberg, Germany.

During this meeting Bang Wong and I hatched the idea of a Nature Methods column that would provide practical advice on the visual presentation of data for researchers. Later that year our August issue featured Bang’s very first Points of View column, “Color coding“. What followed was a labor of love by both Bang and I, with plenty of stress over deadlines, that extended over two years.

The column seemed to fill a need in the community and generated considerable positive feedback, including from authors and reviewers who would sometimes refer to advice from Bang’s columns. At the end of 2012 Bang took a needed break and the column went on hiatus. But in the meantime I had again met someone at a meeting in Germany who was passionately interested in the visual display of data.

The Points of View column returns in our March issue authored by Martin Krzywinski (staff scientist, creator of the visualization software Circos, and former fashion photographer).

I decided we couldn’t let someone with Martin’s varied experiences debut as the new Points of View columnist without learning a bit more about him so I asked our Technology Editor, Vivien Marx, to see what she could dig up.

Martin Krzywinski

Martin Krzywinski

Current mode: Makes cancer research and genome analysis visual.
Introduction to genomics: Built computing infrastructure at Genome Sciences Center
Past activities (incomplete): fashion photography, computer security, particle physics.
Published information graphics (incomplete): Book covers, American Scientist, EMBO Journal, PNAS, The New York Times, Wired, Conde Nast Portfolio.

Alex the rat

Alex the rat

Q: You photographed Alex (2000-2002) and helped her become the poster rat for genome sequencing. For example, she was Genome Research’s rat cover-girl. She frequently rode on your shoulder and seems like a groovy friend.

M.K.: Don’t be fooled by Alex’s visual presentation. She bit me countless times. But what do you expect from a rat? Maybe it is I that never learned.

Q: In addition to photo-shoots with Alex, you have had human fashion models in front of your lens. Fashion is pretty. Why should science be pretty?

Continue reading

What you always wanted to know about histones

Nature Methods and Nature Biotechnology will host a live discussion on why histone modifications matter in health and disease.

Some call it a code, some call it a language. The fact is that core histone proteins that make up the nucloeosme can be modified by a range of post translational modifications (current tally is 16) and that these PTMs, individually or collectively, send a message to the transcription machinery, either attracting or repelling it.

If you have wondered about the nature of the histone code, if you have questions about the importance of its writers, readers and erasers, or wonder how these are changed in some diseases and what can be done about it, an upcoming webcast will give a chance to raise these questions.

On February 26 we will discuss the importance of histone modifications from two aspects. First:  What is the biology behind it? Which enzymes write the code and how important is crosstalk between different modifications?  Second: How can one efficiently target these enzymes to fight disease?

Ali Shilatifard and James Bradner

Our speakers, Ali Shilatifard and James Bradner, will present their views and then they will engage in a live discussion fueled by questions from the audience.

Sign up for the webcast, and post your questions here before February 26, or during the webcast on the event website.  Either way, we will try our best to get them answered.

Note: The live webcast has now concluded. Anyone who wants to see it may still register at the link above and view a recording of the webcast at their leisure.